Detalles de la búsqueda
1.
Silencing of long noncoding RNA MEG3 enhances cerebral protection of dexmedetomidine against hypoxic-ischemic brain damage in neonatal mice by binding to miR-129-5p.
J Cell Biochem
; 120(5): 7978-7988, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30485519
2.
Retracted: microRNA-129-5p involved in the neuroprotective effect of dexmedetomidine on hypoxic-ischemic brain injury by targeting COL3A1 through the Wnt/ß-catenin signaling pathway in neonatal rats.
J Cell Biochem
; 120(5): 6908-6919, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29377229
3.
Neuroprotective effects of dexmedetomidine on traumatic brain injury: Involvement of neuronal apoptosis and HSP70 expression.
Mol Med Rep
; 17(6): 8079-8086, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29693126
4.
Retraction notice to "Dexmedetomidine exerts neuroprotective effect via the activation of the PI3K/Akt/mTOR signaling pathway in rats with traumatic brain injury" [Biomed. Pharmacother. 95 (2017) 885-893].
Biomed Pharmacother
; 169: 115945, 2023 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38008611
5.
Dexmedetomidine exerts neuroprotective effect via the activation of the PI3K/Akt/mTOR signaling pathway in rats with traumatic brain injury.
Biomed Pharmacother
; 95: 885-893, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28903184
6.
PI3K/Akt/mTOR pathway participates in neuroprotection by dexmedetomidine inhibits neuronic autophagy following traumatic brain injury in rats.
Artículo
en Inglés
| IMSEAR | ID: sea-165498
Resultados
1 -
6
de 6
1
Próxima >
>>